Search research articles
Contact Us
Filters
Showing results (261-270 of 659) with videos related to
Page
of 66
Sort By:
JAMA Network Open
|
June 15, 2019
Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma
Pengxiang Li, Jordan Jahnke, Amy R Pettit, et al.
Cancer Research
|
October 1, 1996
Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction
R Bai, R E Schwartz, J A Kepler, et al.
Journal of Natural Products
|
March 1, 2003
Antineoplastic agents. 488. Isolation and structure of yukonin from a yukon territory fungus
George R Pettit, Rui Tan, Delbert L Herald, et al.
Molecular Pharmacology
|
October 1, 1993
Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin
R Bai, Z A Cichacz, C L Herald, et al.
Cancer Research
|
June 1, 1990
Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells
A M Jalava, J Heikkilä, G Akerlind, et al.
Journal of Natural Products
|
January 21, 2010
Antineoplastic agents. 573. isolation and structure of papilistatin from the papilionid butterfly Byasa polyeuctes termessa
George R Pettit, Qinghua Ye, Delbert L Herald, et al.
Cancer Medicine
|
December 2, 2017
Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinoma
Pengxiang Li, Yu-Ning Wong, Jordan Jahnke, et al.
Journal of Experimental Therapeutics & Oncology
|
March 1, 1996
Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts
O Fodstad, K Breistøl, G R Pettit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2017
Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents
Jalpa A Doshi, Pengxiang Li, Hairong Huo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1988
Immunomodulating properties of a novel series of protein kinase C activators. The bryostatins
G Trenn, G R Pettit, H Takayama, et al.
Page
of 66
Search research articles
Search
Showing results (261-270 of 659) with videos related to
Sort By:
Page
of 66
JAMA Network Open
|
June 15, 2019
Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma
Pengxiang Li, Jordan Jahnke, Amy R Pettit, et al.
Cancer Research
|
October 1, 1996
Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction
R Bai, R E Schwartz, J A Kepler, et al.
Journal of Natural Products
|
March 1, 2003
Antineoplastic agents. 488. Isolation and structure of yukonin from a yukon territory fungus
George R Pettit, Rui Tan, Delbert L Herald, et al.
Molecular Pharmacology
|
October 1, 1993
Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin
R Bai, Z A Cichacz, C L Herald, et al.
Cancer Research
|
June 1, 1990
Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells
A M Jalava, J Heikkilä, G Akerlind, et al.
Journal of Natural Products
|
January 21, 2010
Antineoplastic agents. 573. isolation and structure of papilistatin from the papilionid butterfly Byasa polyeuctes termessa
George R Pettit, Qinghua Ye, Delbert L Herald, et al.
Cancer Medicine
|
December 2, 2017
Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinoma
Pengxiang Li, Yu-Ning Wong, Jordan Jahnke, et al.
Journal of Experimental Therapeutics & Oncology
|
March 1, 1996
Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts
O Fodstad, K Breistøl, G R Pettit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2017
Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents
Jalpa A Doshi, Pengxiang Li, Hairong Huo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1988
Immunomodulating properties of a novel series of protein kinase C activators. The bryostatins
G Trenn, G R Pettit, H Takayama, et al.
Page
of 66